Gene therapy involving antibiotics may help patients with Usher syndrome

A new approach to treating vision loss caused by Type 1 Usher syndrome (USH1), the most common condition affecting both sight and hearing, will be unveiled by a scientist at the annual conference of the European Society of Human Genetics today. Ms Annie Rebibo Sabbah, from the Genetics Department of the Rappaport Faculty of Medicine, Technion, Haifa, Israel, will tell the conference that preliminary results using a class of drugs called aminoglycosides, commonly used as antibiotics, had had promising effects in vitro and in cell culture.

Usher syndrome is a recessively- inherited disease; in order to have it, the child must receive a mutated form of the Usher gene from each parent. Approximately 3 to 6 percent of all children who are deaf and another 3 to 6 percent of children who are hard-of-hearing have it. In developed countries, about four babies in every 100,000 births have Usher syndrome. Children born with USH1 begin to develop visual problems in early childhood, and these develop quickly into an eye disorder called retinitis pigmentosa, which leads to complete blindness.

"There are several types of genetic mutations involved in Usher syndrome, including nonsense mutations. In this type of mutations the protein in the cell is totally absent, or abnormally short", says Ms Rebibo Sabbah. "We knew that aminoglycosides are able to suppress nonsense mutations to the extent that, instead of having no protein at all, or a truncated protein, the cell receives a partial amount of full-length protein that may even be functional."

As a model, the team took several nonsense mutations of the PCDH15 gene, which is responsible for Usher syndrome. They were able to produce partial suppression of the mutations in vitro using commercial aminoglycosides. The same result was achieved ex vivo, in cultured cells.
"Despite these promising results, the most serious problem with aminoglycosides is their toxicity to the kidney and to the inner ear, which causes limitation in their use", says Ms Rebibo Sabbah. "We worked with Professor Baasov, from the Chemistry Faculty at Technion, to try to develop a new compound based on aminoglycosides which will have reduced toxicity."

The scientists tested more than forty new compounds for ones which had the same efficacy as aminoglycosides, but with significantly reduced toxicity. "We found a very promising new compound, called NB30", says Ms Rebibo Sabbah. "After testing its toxicity in cells, we tried it in mice. In both models the toxicity was significantly reduced compared to the current commercially available aminoglycosides, and we could also see the suppressive activity of NB30 in the cultured cells."

This is the first time that this therapeutic strategy has been tried in Usher syndrome, the scientists say. Their next step will be to look at another USH1- related gene (CDH23) and its nonsense mutations in both humans and mice.

"Our final aim is to prove that a nonsense mutation underlying Usher syndrome is capable of being suppressed in vivo in a mouse model by commercial aminoglycosides, and also by NB30, and that this will have a positive effect on retinal function", says Ms Rebibo Sabbah. "We will also continue to look for new compounds with improved characteristics."

The researchers hope that their work will lead to therapy to delay the progression and, indeed, the onset, of vision loss in patients with USH1. "Because it is recessively inherited, this is a particularly invidious disease", says Ms Rebibo Sabbah.

"In most cases, parents have normal hearing and vision and are not aware that they are carriers of Usher syndrome. But if they have a child with another carrier, they will have a one in four chance of having a child with the condition at each birth. We need urgently to find an effective treatment."

Source: European Society of Human Genetics

Related stories:

Scientists reveal pivotal hearing structure
In a study published in the September 6, 2007, issue of the journal Nature, researchers showed that two key proteins join together at the precise location where energy of motion is turned into electrical impulses. These proteins, cadherin 23 and protocadherin 15, are part of a complex of proteins called “tip links” that are on hair cells in the inner ear. The tip link is believed to have a central function in the conversion of physical cues into electrochemical signals.
Science's Breakthrough of the Year: Watching evolution in action
Evolution has been the foundation and guiding theory of biology since Darwin gave the theory its proper scientific debut in 1859. But Darwin probably never dreamed that researchers in 2005 would still be uncovering new details about the nuts and bolts of his theory -- how does evolution actually work in the world of influenza genes and chimpanzee genes and stickleback fish armor? Studies that follow evolution in action claim top honors as the Breakthrough of the Year, named by Science and its publisher AAAS, the nonprofit science society.
Cornell Finds Natural Selection in Humans
The most detailed analysis to date of how humans differ from one another at the DNA level shows strong evidence that natural selection has shaped the recent evolution of our species, according to researchers from Cornell University, Celera Genomics and Celera Diagnostics.
Short RNAs show a long history
MicroRNAs, the tiny molecules that fine-tune gene expression, were first discovered in 1993. But it turns out they've been around for a billion years.
As personalized, genomic medicine takes off, four developing countries show the way for others
Developing countries that want the benefits of cutting-edge health care possibilities based on the genetic variation of individual citizens and sub-populations need to foster the new science at home, says a major new Canadian study published today by Nature Publishing Group.
Sellers squawk as eBay evolves to combat rivals
Flocks of eBay sellers were squawking as the pioneering online auction website continued "bold changes" aimed at wrenching market share from Internet retail giant Amazon.
Next-gen broadband at your service
Faster, smarter broadband networks are on the way, thanks to European research. The next step will be to usher in compelling services for European consumers. Already companies are eager to get their hands on the technologies developed by the MUSE project.
Intel Outlines Plans for New Category of Smarter, Purpose-Built 'System on Chip' Designs
As Internet access continues to be added to all kinds of computers and devices, Intel executives outlined a plan to use its chip design expertise, factory capacity, advanced manufacturing techniques and the economics of Moore's Law to usher in a new category of highly integrated, purpose-built and Web-savvy System on Chip (SoC) designs and products. The company also unveiled its first eight such products under its Intel EP80579 Integrated Processor family for security, storage, communications, and industrial robotics.

News discussion:

Medicine & Health news